Adherence to BCR-ABL inhibitors: issues for CML therapy.
about
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemiasEuropean Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsMilestones and monitoring.Protecting pediatric oncology patients from influenzaImproving adherence to oral cancer therapy in clinical practice.Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients.First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY.Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome.Oral Chemotherapy in Patients with Hematological Malignancies-Care Process, Pharmacoeconomic and Policy Implications.Assay of OAZ1 mRNA levels in chronic myeloid leukemia combined with application of leukemia PCR array identified relevant gene changes affected by antizyme.Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib.Lack of congruence between patients' and health professionals' perspectives of adherence to imatinib therapy in treatment of chronic myeloid leukemia: A qualitative study
P2860
Q33714727-95C4B486-2E37-49DE-AD0E-D8CF9DD4AB48Q35051720-2B79B68F-0732-4688-ACA4-C82189A4A15CQ35652844-C8E649F0-E7FB-4FC0-A539-0678D05793A3Q36630470-515E1AB4-6379-466E-863F-987807891DB9Q38216035-8796F940-A3AC-4D35-B64E-050599648124Q38356369-36983987-5107-4BA0-8A2C-734D16AFE2EFQ38620872-0B250EBF-342A-4E59-985B-49A8905090A0Q38797683-EC386D89-D589-40B1-AC99-5EC89508DD53Q38810189-D8EF04D7-55AD-4DE0-B6EC-0C9F6FFB6AEAQ45184366-6FB8FA25-56B1-462E-9C99-14AFD77B86B8Q53026370-28C66554-93E9-4BB0-9C8A-E13D7274A6E9Q57143102-47C5F045-B8BA-4B81-A802-8D330D9D1ADF
P2860
Adherence to BCR-ABL inhibitors: issues for CML therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Adherence to BCR-ABL inhibitors: issues for CML therapy.
@ast
Adherence to BCR-ABL inhibitors: issues for CML therapy.
@en
type
label
Adherence to BCR-ABL inhibitors: issues for CML therapy.
@ast
Adherence to BCR-ABL inhibitors: issues for CML therapy.
@en
prefLabel
Adherence to BCR-ABL inhibitors: issues for CML therapy.
@ast
Adherence to BCR-ABL inhibitors: issues for CML therapy.
@en
P2860
P1476
Adherence to BCR-ABL inhibitors: issues for CML therapy.
@en
P2093
Giuseppe Saglio
Jerald Radich
P2860
P304
P356
10.1016/J.CLML.2012.04.002
P407
P577
2012-05-24T00:00:00Z